Restore Hyper Wellness has declared May its first

Tune Therapeutics will present late-breaking Phas

ROKIT Healthcare presented clinical outcomes of a

Neuraly, Inc.

Partners can offer clinician-guided peptide ther

The company stops its Phase 2 study of nivisneba

Chi Longevity reflects growing convergence of pr

Allen Law shares his blueprint for closing the h

BioAge will host an R&D Day webcast on 8 May 2026

Clene received final minutes from a Type C meetin

Niagen Bioscience has launched Niagen Plus, a cli

GlycanAge will convene leading academics and clin

Four-day longevity gathering to convene scientis

Prescription-only Niagen kit brings at-home deli

Strategic market intelligence partnership connec

From overlooked sugar molecules to early disease

Lineage Cell Therapeutics presented 36-month resu

Rokit Healthcare is accelerating the commercializ

Alnylam will present new analyses of Vutrisiran f

Newly published trial data show cognitive gains

New research shows sugar doesn’t just damage s

Early clinical data from Aspen Neuroscience sugg

Positive FDA feedback signals momentum for a rar

Scribe Therapeutics will present engineered CRISP

LifespanningRx launched a Partner Program that en

A new deal moves spermidine from supplements to

EvergoldLongevity’s Simone Rossignol explains

New filing expands NorthStrive Biosciences’ pu

Real-time clinical trials could accelerate drug

A genome pioneer who read life as code – and r

BioCardia announced the allowance of a Japanese p

Insilico Medicine announced that the inhalation f

Alector confirmed it will discontinue the Phase 2

Stealth provided a commercial and research update

Renibus announced that data from the Phase 3 PROT

Deal strengthens cyclodextrin IP targeting ApoE4

A new obesity approach targets fat storage pathw

Sana and Mayo Clinic partner to advance a potent

Metashape Pharma announced that new preclinical d

VectorY Therapeutics has received authorization f

Leading experts warn that ageism and outdated bu

NorthStrive Biosciences Inc.

NorthStrive Biosciences Inc.

Aesthetic Record has acquired Joya Health, a corp

The molecular biology firm joins the Tobacco Doc

The Super Age Games introduce a new competition

Munich startup dehaze targets earlier detection

Deal unites clinical diagnostic powerhouse with

Alterity Therapeutics received positive regulator

Aspen presented 12-month data from the first eigh